For 2017, 8 401 cases were reported in the EU/EEA, 8 393 (99.9%) of which were confirmed. Twenty-one confirmed cases were reported as acquired in the EU.
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 9-15 June 2019 and includes updates on cholera, measles, dengue, Ebola virus disease, West Nile virus infection, chlamydia trachomatic testing and Salmonella Enteriditis associated with travel on cruise ships.
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 19-25 May 2019 and includes updates on rat hepatitis B, dengue, Ebola virus disease, influenza, Legionnaires' disease and P. vivax malaria.
In 2017, 42 242 cases of pertussis were reported in EU/EEA countries. Five countries (Germany, the Netherlands, Poland, Spain and the UK) accounted for 76% of all notified cases.